Furthermore, regulatory T cells (Tregs) may suppress immune responses in DCIS through the expression of negative co-stimulatory molecules, such as PD-1, PD-L1, and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) [78,89]. The gene discussed is CTLA4; the disease is ductal breast carcinoma in situ.